PXPXS RESEARCH
Physical AI

Current stock research snapshot · 8/6/26 20 days old

IARTIntegra LifeSciences Holdings

Add to comparison ↗Open IART in Robinhood ↗
POOL
Investment conviction●●○○○2 of 5 · current snapshot
Research target$31.71Current stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed 8/6/26
Market cap$1.45BSnapshot value · 8/6/26
Research history

What changed

See all IART changes ↗

Target
$31.60 → $31.71

Current investment thesis

Medical devices for neurosurgery, reconstructive surgery, and wound care — surgical instruments (dural repair, tissue reconstruction), skin regeneration (Integra artificial skin), and SurgiMend collagen matrix. NOT robotics.

Current stock catalysts

Q2 2026 earnings ~late Jul; FY EPS raised to $2.40-2.50; SurgiMend Braintree facility production started end Jun 2026; Argus upgrade to Buy $25; neurosurgery instrument growth stable

Current investment risks

needs primary source validation

Stock social sentiment

needs primary source validation

Snapshot · 8/6/26
Institutional positioning

🟡 Mixed · ins+$0.1M(1buy) · 13F 14+/9-×0.5 · short↑0.41

Snapshot · 8/6/26